Literature DB >> 17698851

Phospholemman transmembrane structure reveals potential interactions with Na+/K+-ATPase.

Andrew J Beevers1, Andreas Kukol.   

Abstract

Phospholemman (PLM) is a 72-residue bitopic cardiac transmembrane protein, which acts as a modulator of the Na(+)/K(+)-ATPase and the Na(+)/Ca(2+) exchanger and possibly forms taurine channels in nonheart tissue. This work presents a high resolution structural model obtained from a combination of site-specific infrared spectroscopy and experimentally constrained high throughput molecular dynamics (MD) simulations. Altogether, 37 experimental constraints, including nine long range orientational constraints, have been used during MD simulations in an explicit lipid bilayer/water system. The resulting tetrameric alpha-helical bundle has an average helix tilt of 7.3 degrees and a crossing angle close to 0 degrees . It does not reveal a hydrophilic pore, but instead strong interactions between various residues occlude any pore. The helix-helix packing is unusual, with Gly(19) and Gly(20) pointing to the outside of the helical bundle, facilitating potential interaction with other transmembrane proteins, thus providing a structural basis for the modulatory effect of PLM on the Na(+)/K(+)-ATPase. A two-stage model of interaction between PLM and the Na(+)/K(+)-ATPase is discussed involving PLM-ATPase interaction and subsequent formation of an unstable PLM trimer, which readily interacts with surrounding ATPase molecules. Further unconstrained MD simulations identified other packing models of PLM, one of which could potentially undergo a conformational transition to an open pore.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698851     DOI: 10.1074/jbc.M703676200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Residues 248-252 and 300-304 of the cardiac Na+/Ca2+ exchanger are involved in its regulation by phospholemman.

Authors:  Xue-Qian Zhang; JuFang Wang; Jianliang Song; Angi M Ji; Tung O Chan; Joseph Y Cheung
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-06       Impact factor: 4.249

2.  Phospholemman, a major regulator of skeletal muscle Na+/K+-ATPase, is not mutated in probands with hypokalemic periodic paralysis.

Authors:  Ying-Ying Chen; Xiao-Ying Wang; Qiu-Xia Fu; Yi Kang; He-Bin Yao
Journal:  Exp Ther Med       Date:  2017-07-28       Impact factor: 2.447

3.  Phosphomimetic mutations enhance oligomerization of phospholemman and modulate its interaction with the Na/K-ATPase.

Authors:  Qiujing Song; Sandeep Pallikkuth; Julie Bossuyt; Donald M Bers; Seth L Robia
Journal:  J Biol Chem       Date:  2011-01-10       Impact factor: 5.157

4.  L30A Mutation of Phospholemman Mimics Effects of Cardiac Glycosides in Isolated Cardiomyocytes.

Authors:  Ryan D Himes; Nikolai Smolin; Andreas Kukol; Julie Bossuyt; Donald M Bers; Seth L Robia
Journal:  Biochemistry       Date:  2016-10-25       Impact factor: 3.162

5.  FXYD proteins and sodium pump regulatory mechanisms.

Authors:  John Q Yap; Jaroslava Seflova; Ryan Sweazey; Pablo Artigas; Seth L Robia
Journal:  J Gen Physiol       Date:  2021-04-05       Impact factor: 4.086

Review 6.  Regulation of the cardiac sodium pump.

Authors:  W Fuller; L B Tulloch; M J Shattock; S C Calaghan; J Howie; K J Wypijewski
Journal:  Cell Mol Life Sci       Date:  2012-09-07       Impact factor: 9.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.